Clinical Trials Browser

Phase 1 × Breakthrough Pain × Clear all

NCT00125294 2017-09-25

Sublingual Methadone for the Management of Cancer Breakthrough Pain

Phase 1 Completed

Cancer Pain, Neoplasms, Pain, Breakthrough Pain